Suzhou Basecare Medical Corporation Limited
Research Suzhou Basecare Medical Corporation Limited (2170.HK) on Bullrun: market cap HKD 361.03M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2170.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryMedical Devices
- CurrencyHKD
- Market capHKD 361.03M
- Financial periodFY2025
- RevenueCNY 233.27M
- Revenue growth-22.0%
- Net income-CNY 223.46M
- Free cash flow-CNY 253.45M
- Gross margin53.0%
Valuation Snapshot
latest market cap is HKD 361.03M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 233.27M | -CNY 223.46M | -CNY 253.45M | 53.0% | n/a | CNY 414.91M | CNY 343.36M | CNY 934.67M |
| FY2024 | CNY 299.11M | -CNY 237.03M | -CNY 322.41M | 45.5% | -0.9 | CNY 572.75M | CNY 328.42M | CNY 1.14B |
| FY2023 | CNY 207.98M | -CNY 191.69M | -CNY 371.44M | 43.9% | -0.7 | CNY 943.22M | CNY 281.92M | CNY 1.40B |
| FY2022 | CNY 140.90M | -CNY 122.66M | -CNY 317.52M | 42.2% | -0.5 | CNY 1.33B | CNY 75.54M | CNY 1.59B |
| FY2021 | n/a | n/a | n/a | n/a | -0.5 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 361.03M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Suzhou Basecare Medical Corporation Limited
Suzhou Basecare Medical Corporation Limited, an investment holding company provides genetic testing solutions for assisted human reproduction in the People's Republic of China and Australia. The company offers pre-implantation genetic test kits, including PGT-A kit to detect aneuploidy; PGT-M kit to detect single-gene or monogenic defects in pre-implantation embryos;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Suzhou Basecare Medical Corporation Limited's market cap?
Suzhou Basecare Medical Corporation Limited's market capitalization is HKD 361.03M.
What does Suzhou Basecare Medical Corporation Limited do?
Suzhou Basecare Medical Corporation Limited, an investment holding company provides genetic testing solutions for assisted human reproduction in the People's Republic of China and Australia. The company offers pre-implantation genetic test kits, including PGT-A kit to detect aneuploidy; PGT-M kit to detect single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kit to detect chromosome structural rearrangements, which are common causes of recurrent miscarriage, implantation failures, and birth defects.